Anticoagulation Therapy in Atrial Fibrillation in Combination With Acute Myocardial Infarction Influences Long-Term Outcome | Zendy

Ulf Stenestrand | Zendy; Johan Lindbäck | Zendy; Lars Wallentin | Zendy

Open Access

Anticoagulation Therapy in Atrial Fibrillation in Combination With Acute Myocardial Infarction Influences Long-Term Outcome

Author(s) -

Ulf Stenestrand,

Johan Lindbäck,

Lars Wallentin

Publication year - 2005

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.105.552984

Subject(s) - medicine , atrial fibrillation , myocardial infarction , stroke (engine) , confounding , antithrombotic , proportional hazards model , cardiology , prospective cohort study , medical prescription , mortality rate , heart failure , cohort study , mechanical engineering , engineering , pharmacology

The American and European guidelines do not agree with regard to antithrombotic treatment in patients with atrial fibrillation (AF) and acute myocardial infarction (AMI), thus causing uncertainty among physicians. We investigated the prescription of oral anticoagulation (OAC) in patients discharged alive with AF after an AMI and the influence of OAC treatment on 1-year mortality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research